MFDS — authorised 16 March 1976
- Marketing authorisation holder: XSPIRE
- Status: likely_approved
🇰🇷 Nalfon in South Korea
MFDS authorised Nalfon on 16 March 1976
Marketing authorisation
Nalfon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Nalfon approved in South Korea?
Yes. MFDS authorised it on 16 March 1976.
Who is the marketing authorisation holder for Nalfon in South Korea?
XSPIRE holds the South Korean marketing authorisation.